MY name is Jak.stat, not jac and the company's name is ABBOTT, not Abbot.
As to the essence of your question: I see ABT still very overpriced given the fact that a) investors have no appetite for companies trading at P/E of 14+ b) there are many unknowns with respect to the immediate and mid-term prospects of the health care companies c) ABT is pumped by characters on public media which in my eyes are completely and totally discredited d) the history of ABT with Miles White at the helm is a disappointment because of the continuous succession of "one-time quaterly charges" which all add up to de facto no growth.
As for my credentials, I am a scientist. Never worked for ABT, have held considerable position in ABT for more than two dsecades and a) will not sell at current prices b) will sell if political situation gets clarified and ABT goes to %% which may be years from now.
yes, i would like to use my brains, should i buy this stock since it is at a new low of 43, please respond seriously, thankyou,,,,my goal to is to buy at 43-44 and sell at end of month believing this could go up to 50 again, like celg did was low a few days ago and then climbed up a few .. i dont want to miss another pharma stock that has hit a new low etc..